Lv4
680 积分 2023-01-17 加入
Lazertinib Versus Osimertinib in EGFR-Mutant NSCLC: Efficacy, Toxicity, and Unaddressed Clinical Gaps
1个月前
已关闭
313 Osimertinib tolerance and sustained disease control in recurrent squamous cell lung cancer with rare compound EGFR mutations (G719A and H773L)
1个月前
已完结
Management of periungual pyogenic granulomas due to EGFR inhibitors in real world
1个月前
已完结
201eP Safety of first-line osimertinib in patients with EGFRm locally advanced or metastatic non-small cell lung cancer: OSIREAL study
1个月前
已关闭
Marked Reduction in Tacrolimus and Everolimus Blood Levels Associated With Sotorasib: A Critical Drug Interaction in a Kidney Transplant Recipient
1个月前
已关闭
4MO Updated results for MK-1084 + pembrolizumab in KRAS G12C-mutated (mut) metastatic non-small cell lung cancer (mNSCLC) enrolled in KANDLELIT-001
1个月前
已完结
S3812 A Rare Event of Acute Hepatic Failure Due to Sotorasib: A Case Report
1个月前
已关闭
Opioid toxicity from impaired oxycodone metabolism associated with adagrasib
1个月前
已完结
A 71-Year-Old Woman With Dyspnea and Hypoxemia After Liver Metastases Cryoablation
1个月前
已完结
皖公网安备34019202002308
